Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CLTB | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | DTL | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | TMEM30A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | SLCO3A1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | AIFM1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | SORCS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | RNF8 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | RAD52 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | CD276 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | DYNC1LI1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |